Figures 3 and 9 show the attenuation of PQ-induced lung fibrosis by ligustrazin treatment and its association with increased miR-193a expression and blocking of the SMAD2/TGF-β1 signalling pathway and CTGF protein expression. The gene discussed is SMAD2; the disease is pulmonary fibrosis.